Terms: = Pancreatic cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Diagnosis
74 results:
1. E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated emt via destabilization of OGA.
Du Y; Yang Z; Shi H; Chen Z; Chen R; Zhou F; Peng X; Hong T; Jiang L
Cell Death Dis; 2024 May; 15(5):340. PubMed ID: 38755129
[TBL] [Abstract] [Full Text] [Related]
2. Identification of a robust biomarker LAPTM4A for glioma based on comprehensive computational biology and experimental verification.
Ding Y; Jiang Y; Zeng H; Zhou M; Zhou X; Yu Z; Pan J; Geng X; Zhu Y; Zheng H; Huang S; Gong Y; Huang H; Xiong C; Huang D
Aging (Albany NY); 2024 Apr; 16(8):6954-6989. PubMed ID: 38613802
[TBL] [Abstract] [Full Text] [Related]
3. FUT4 promotes the progression of Cholangiocarcinoma by modulating epithelial-mesenchymal transition.
Liu E; Qian X; He Y; Chen K
Cell Cycle; 2024 Jan; 23(2):218-231. PubMed ID: 38466946
[TBL] [Abstract] [Full Text] [Related]
4. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.
Di X; Wang D; Wu J; Zhu X; Wang Y; Yan J; Wen L; Jiang H; Wen D; Shu B; Zhang S
Gene; 2024 May; 908():148304. PubMed ID: 38387708
[TBL] [Abstract] [Full Text] [Related]
6. Exosomal non-coding RNA: A new frontier in diagnosing and treating pancreatic cancer: A review.
Sha G; Zhang W; Jiang Z; Zhao Q; Wang D; Tang D
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130149. PubMed ID: 38365161
[TBL] [Abstract] [Full Text] [Related]
7. FOXA2-initiated transcriptional activation of INHBA induced by methylmalonic acid promotes pancreatic neuroendocrine neoplasm progression.
Hu C; Ye M; Bai J; Liu P; Lu F; Chen J; Xu Y; Yan L; Yu P; Xiao Z; Gu D; Xu L; Tian Y; Tang Q
Cell Mol Life Sci; 2024 Jan; 81(1):50. PubMed ID: 38252148
[TBL] [Abstract] [Full Text] [Related]
8. High-Fat Mouse Model to Explore the Relationship between Abnormal Lipid Metabolism and Enolase in pancreatic cancer.
Qin L; Sun K; Shi L; Xu Y; Zhang R
Mediators Inflamm; 2023; 2023():4965223. PubMed ID: 37731842
[TBL] [Abstract] [Full Text] [Related]
9. GABRP Promotes the Metastasis of pancreatic cancer by Activation of the MEK/ERK Signaling Pathway.
Meng Y; Li R; Geng S; Chen W; Jiang W; Li Z; Hao J; Xu Z
Biochem Genet; 2024 Feb; 62(1):242-253. PubMed ID: 37326897
[TBL] [Abstract] [Full Text] [Related]
10. Notch signaling pathway in pancreatic tumorigenesis.
Chung WC; Xu K
Adv Cancer Res; 2023; 159():1-36. PubMed ID: 37268393
[TBL] [Abstract] [Full Text] [Related]
11. LncRNA FAM83A-AS1 promotes epithelial-mesenchymal transition of pancreatic cancer cells via Hippo pathway.
Wang H; Ding Y; Zhu Q; Yu Z; Wang Q; Gong A; Xu M
Cell Cycle; 2023 Jun; 22(12):1514-1527. PubMed ID: 37245082
[TBL] [Abstract] [Full Text] [Related]
12. Histone Modifications Represent a Key Epigenetic Feature of Epithelial-to-Mesenchyme Transition in pancreatic cancer.
Xu Y; Zhu Q
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902253
[TBL] [Abstract] [Full Text] [Related]
13. Cell Dissemination in pancreatic cancer.
Kim J
Cells; 2022 Nov; 11(22):. PubMed ID: 36429111
[TBL] [Abstract] [Full Text] [Related]
14. emt Molecular Signatures of pancreatic Neuroendocrine Neoplasms.
Venugopal A; Michalczyk A; Khasraw M; Ackland ML
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362433
[TBL] [Abstract] [Full Text] [Related]
15. A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma.
Yang H; Zhang W; Ding J; Hu J; Sun Y; Peng W; Chu Y; Xie L; Mei Z; Shao Z; Xiao Y
Front Immunol; 2022; 13():970588. PubMed ID: 36148233
[TBL] [Abstract] [Full Text] [Related]
16. Oncogenic roles of LINC01234 in various forms of human cancer.
Kong M; Yu X; Zheng Q; Zhang S; Guo W
Biomed Pharmacother; 2022 Oct; 154():113570. PubMed ID: 36030582
[TBL] [Abstract] [Full Text] [Related]
17. Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associated with Hepatocellular Carcinoma.
Tian Y; Lei Y; Fu Y; Sun H; Wang J; Xia F
Curr Cancer Drug Targets; 2022; 22(6):454-462. PubMed ID: 35362393
[TBL] [Abstract] [Full Text] [Related]
18. Functional mechanism of hsa-miR-128-3p in epithelial-mesenchymal transition of pancreatic cancer cells via ZEB1 regulation.
Zheng T; Han W; Wang A; Wang Y
PeerJ; 2022; 10():e12802. PubMed ID: 35186455
[TBL] [Abstract] [Full Text] [Related]
19. Methylation‑associated inactivation of JPH3 and its effect on prognosis and cell biological function in HCC.
Huang Y; Yu Z; Zheng M; Yang X; Huang H; Zhao L
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35169860
[TBL] [Abstract] [Full Text] [Related]
20. Quercetin Impact in pancreatic cancer: An Overview on Its Therapeutic Effects.
Asgharian P; Tazehkand AP; Soofiyani SR; Hosseini K; Martorell M; Tarhriz V; Ahangari H; Cruz-Martins N; Sharifi-Rad J; Almarhoon ZM; Ydyrys A; Nurzhanyat A; Yessenbekova A; Cho WC
Oxid Med Cell Longev; 2021; 2021():4393266. PubMed ID: 34777687
[TBL] [Abstract] [Full Text] [Related]
[Next]
